By placing the lipogenic master regulator SREBP-1c as one of the select target genes coregulated by STAT5 and PR-B, we can explain the PR-B isoform-specific regulatory actions on the cross-talk between prolactin and FASN signaling in luminal breast cancer cells (Figure 6). The gene discussed is PRL; the disease is breast carcinoma.